What is Hypertrophic Cardiomyopathy?
Hypertrophic cardiomyopathy (HCM) is a common hereditary medical condition that afflicts one in 500 Americans. HCM results in the walls of the heart becoming excessively thick and it may obstruct blood flow from leaving the heart. Symptoms often overlap other medical ailments and treating it can be complex. It is a genetic disease and more than one family member may be affected.
Chanin T. Mast Center for Hypertrophic Cardiomyopathy
The founding principle of our program at Gagnon Cardiovascular Institute at Morristown Medical Center, part of Atlantic Health System Heart Care, is to provide nurturing, personalized care to patients with known or suspected HCM. Led by our internationally recognized expert in HCM, this comprehensive multidisciplinary HCM program is the first of its kind in New Jersey. We provide world-class HCM care to patients throughout the state and region.
We provide the following services:
- Convenient access to specialists and our world-renowned medical director
- Individualized coordinated multidisciplinary evaluation, management and patient/family support
- Imaging and diagnostics as well as access to interventions including implantation of defibrillators, surgery and catheter-based interventions
- HCM screenings and community outreach to help protect young athletes from sudden cardiac death
If you have a family history of cardiomyopathy, aortic root enlargement or structural cardiac abnormalities, a genetic evaluation may be helpful.